Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
27 results
D2.127 - The bacterial lysate OM-85 mitigates HDM-induced allergic inflammation through the airway epithelial cell- macrophage crosstalk
D2.299 - A novel synthetic molecule LN49 suppressed oxidative stress and inflammation in skin epithelial and fibroblast cells via activating Nrf-2 signaling pathway
D2.306 - Sodium dodecyl sulfate impairs the skin epithelial barrier by inducing oxidative stress in human skin
D3.142 - Differential Impact of Heat-not-Burn Tobacco Products and Conventional Cigarettes on Pulmonary Cells and Immune Response
D3.372 - SLC27A2 marks lipid peroxidation in nasal epithelial cells driven by type 2 inflammation in chronic rhinosinusitis with nasal polyps
D3.432 - Anti-inflammatory properties of IPA on epithelial barrier sites
D3.433 - Transcriptome kinetics of esophageal epithelial cells in response to interleukin 13
D2.390 - Effects of Cigarette Smoke on Expression and Rhythmicity ofr Core Circadian Genes in Peripheral Blood Mononuclear Cells (PBMC) and Bronchial Epithelial Cells
000766 - Clonal mast cell disorders, allergy to hymenoptera venom and venom immunotherapy – our experience
001066 - The Impact of Bee Sting Experiences on Quality of Life and Perceived Health Threat in Korean Beekeepers with Bee Venom Allergy
100085 - Code Anaphylaxis: enhancing the management of Hymenoptera venom anaphylaxis
D1.162 - Selecting the right immunotherapy for Vespa velutina nigrithorax anaphylaxis: does one treatment fits all?
D2.75 - Allergy to insects in children
D3.423 - Cross-Reactivity Among Hymenoptera Venoms: A Case Study on Apis, Vespula, and Polistes Allergens
D3.195 - Reasons for declining venom immunotherapy and its burden on patients' daily lives
D3.198 - Hymenoptera Venom Allergy: A Case Report on Safe Discontinuation After Five Years of Venom Immunotherapy
D3.203 - Yeast surface display as platform for generation of nanobodies to single allergens and allergen extracts
D3.424 - Long-term efficacy and re-sting outcomes following venom immunotherapy discontinuation: A 978-patient analysis
D3.425 - Anaphylactic reaction to carpenter bee
D3.426 - The Frequency of Previous Large Local Reactions in a Group of 158 Patients with a History of Systemic Reaction after Insect Sting
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download